title: Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Gauthier
authors.forename: N
authors.initials: N
authors.lastname: Bodick
authors.forename: E
authors.initials: E
authors.lastname: Erzigkeit
authors.forename: H
authors.initials: H
authors.lastname: Feldman
authors.forename: D S
authors.initials: DS
authors.lastname: Geldmacher
authors.forename: J
authors.initials: J
authors.lastname: Huff
authors.forename: R
authors.initials: R
authors.lastname: Mohs
authors.forename: J M
authors.initials: JM
authors.lastname: Orgogozo
authors.forename: S
authors.initials: S
authors.lastname: Rogers
mesh_terms: D000203:Activities of Daily Living / Q000145:classification*; D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy*; D015577:Geriatric Assessment; D006801:Humans; D007391:International Cooperation; D018697:Nootropic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
chemical_list: D018697:Nootropic Agents